Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is MELD really the definitive score for liver allocation?

Laura Lladó1, Juan Figueras, Roberto Memba

  • 1Liver Transplant Unit, Department of Surgery, CSU de Bellvitge, University of Barcelona, Barcelona, Spain.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|August 30, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to: "The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1" [JHEP Reports 8 (2026) 101755].

JHEP reports : innovation in hepatology·2026
Same author

Identifying Predictors of Failure-to-Rescue after Liver Transplantation: A Multicenter Analysis of 1341 Patients.

Clinical transplantation·2026
Same author

De Novo Cancer in Liver Transplant Patients With Human Immunodeficiency Virus Infection: A Multicenter Nationwide Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial.

BMJ open·2026
Same author

The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1.

JHEP reports : innovation in hepatology·2026
Same author

Consensus statement on obesity management in liver transplantation candidates.

Updates in surgery·2026

Organ allocation scores like MELD and Child-Pugh show limited accuracy in predicting liver transplant waiting list mortality. These scores may not fully capture patient severity, especially those with cancer.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Medical Informatics

Background:

  • Organ allocation systems are crucial for equitable distribution.
  • Predictive scoring systems aim to optimize organ allocation by assessing patient prognosis.
  • Current scores may have limitations in accurately predicting mortality on the liver transplant waiting list.

Discussion:

  • All evaluated scores, except the Freeman scale, were significantly higher in patients who died on the waiting list compared to those transplanted.
  • Despite statistical significance for MELD, Child-Pugh, and Guardiola scores, their C-statistics were all below 0.8, indicating suboptimal predictive accuracy.
  • The Model for End-Stage Liver Disease (MELD) score, while readily available and objective, may not adequately capture disease severity in patients with specific conditions like hepatocellular carcinoma or metabolic disorders.

Related Experiment Videos

Key Insights:

  • No single scoring system demonstrated excellent accuracy in predicting liver transplant waiting list mortality across all patient groups.
  • The predictive performance of current scores is particularly limited in patient populations with a high prevalence of hepatocellular carcinoma.
  • The study highlights limitations of existing scores in reflecting the full spectrum of disease severity, especially for complex cases.

Outlook:

  • Further research is needed to develop and validate novel scoring systems that offer improved accuracy for organ allocation.
  • Refining existing scores or developing new ones should consider specific patient subgroups, such as those with hepatocellular carcinoma.
  • Enhanced prognostic tools are crucial for optimizing organ allocation strategies and improving outcomes for patients awaiting liver transplantation.